Selected research
Industry Research
Lorazepam Tablets Industry Research Report 2026
Market perspective
The global Lorazepam Tablets market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
The North America market for Lorazepam Tablets is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.
The Europe market for Lorazepam Tablets is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.
Read the full market overview
The Asia Pacific market for Lorazepam Tablets is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.
Leading global manufacturers of Lorazepam Tablets include Teva, Shandong Sinepharm, Sandoz, Mylan, Pfizer, Huazhong Yaoye, Hunan Dongting Pharmaceutical, Major Pharmaceuticals and Leading Pharma, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report quantifies the global Lorazepam Tablets market in terms of revenue (US$ million) and, where applicable, sales volume (K Units), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/K Units) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Lorazepam Tablets Market by Company
Teva
Shandong Sinepharm
Sandoz
Mylan
Pfizer
Huazhong Yaoye
Hunan Dongting Pharmaceutical
Major Pharmaceuticals
Leading Pharma
Hemofarm
Bausch Health
Aurobindo
Lorazepam Tablets Segment by Type
0.5mg
1mg
2mg
Lorazepam Tablets Segment by Application
Recovery Center
Hospital
Clinics
Lorazepam Tablets Segment by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Netherlands
Nordic Countries
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
South America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Lorazepam Tablets market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Lorazepam Tablets and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Lorazepam Tablets.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Lorazepam Tablets manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Lorazepam Tablets by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Lorazepam Tablets in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- 0.5mg
- 1mg
- 2mg
Applications
- Recovery Center
- Hospital
- Clinics
Companies covered
- Teva
- Shandong Sinepharm
- Sandoz
- Mylan
- Pfizer
- Huazhong Yaoye
- Hunan Dongting Pharmaceutical
- Major Pharmaceuticals
- Leading Pharma
- Hemofarm
- Bausch Health
- Aurobindo
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Global Market Growth Prospects
- 2.2.1 Global Lorazepam Tablets Market Size (2021-2032)
- 2.2.2 Global Lorazepam Tablets Sales (2021-2032)
- 2.2.3 Global Lorazepam Tablets Market Average Price (2021-2032)
- 2.3 Lorazepam Tablets by Type
- 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
- 2.3.2 0.5mg
- 2.3.3 1mg
- 2.3.4 2mg
- 2.4 Lorazepam Tablets by Application
- 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.4.2 Recovery Center
- 2.4.3 Hospital
- 2.4.4 Clinics
3 Market Competitive Landscape by Manufacturers
- 3.1 Global Lorazepam Tablets Market Competitive Situation by Manufacturers (2021 Versus 2025)
- 3.2 Global Lorazepam Tablets Sales (K Units) of Manufacturers (2021-2026)
- 3.3 Global Lorazepam Tablets Revenue of Manufacturers (2021-2026)
- 3.4 Global Lorazepam Tablets Average Price by Manufacturers (2021-2026)
- 3.5 Global Lorazepam Tablets Industry Ranking, 2024 VS 2025 VS 2026
- 3.6 Global Manufacturers of Lorazepam Tablets, Manufacturing Sites & Headquarters
- 3.7 Global Manufacturers of Lorazepam Tablets, Product Type & Application
- 3.8 Global Manufacturers of Lorazepam Tablets, Established Date
- 3.9 Global Lorazepam Tablets Market CR5 and HHI
- 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
- 4.1 Teva
- 4.1.1 Teva Company Information
- 4.1.2 Teva Business Overview
- 4.1.3 Teva Lorazepam Tablets Sales, Revenue and Gross Margin (2021-2026)
- 4.1.4 Teva Lorazepam Tablets Product Portfolio
- 4.1.5 Teva Recent Developments
- 4.2 Shandong Sinepharm
- 4.2.1 Shandong Sinepharm Company Information
- 4.2.2 Shandong Sinepharm Business Overview
- 4.2.3 Shandong Sinepharm Lorazepam Tablets Sales, Revenue and Gross Margin (2021-2026)
- 4.2.4 Shandong Sinepharm Lorazepam Tablets Product Portfolio
- 4.2.5 Shandong Sinepharm Recent Developments
- 4.3 Sandoz
- 4.3.1 Sandoz Company Information
- 4.3.2 Sandoz Business Overview
- 4.3.3 Sandoz Lorazepam Tablets Sales, Revenue and Gross Margin (2021-2026)
- 4.3.4 Sandoz Lorazepam Tablets Product Portfolio
- 4.3.5 Sandoz Recent Developments
- 4.4 Mylan
- 4.4.1 Mylan Company Information
- 4.4.2 Mylan Business Overview
- 4.4.3 Mylan Lorazepam Tablets Sales, Revenue and Gross Margin (2021-2026)
- 4.4.4 Mylan Lorazepam Tablets Product Portfolio
- 4.4.5 Mylan Recent Developments
- 4.5 Pfizer
- 4.5.1 Pfizer Company Information
- 4.5.2 Pfizer Business Overview
- 4.5.3 Pfizer Lorazepam Tablets Sales, Revenue and Gross Margin (2021-2026)
- 4.5.4 Pfizer Lorazepam Tablets Product Portfolio
- 4.5.5 Pfizer Recent Developments
- 4.6 Huazhong Yaoye
- 4.6.1 Huazhong Yaoye Company Information
- 4.6.2 Huazhong Yaoye Business Overview
- 4.6.3 Huazhong Yaoye Lorazepam Tablets Sales, Revenue and Gross Margin (2021-2026)
- 4.6.4 Huazhong Yaoye Lorazepam Tablets Product Portfolio
- 4.6.5 Huazhong Yaoye Recent Developments
- 4.7 Hunan Dongting Pharmaceutical
- 4.7.1 Hunan Dongting Pharmaceutical Company Information
- 4.7.2 Hunan Dongting Pharmaceutical Business Overview
- 4.7.3 Hunan Dongting Pharmaceutical Lorazepam Tablets Sales, Revenue and Gross Margin (2021-2026)
- 4.7.4 Hunan Dongting Pharmaceutical Lorazepam Tablets Product Portfolio
- 4.7.5 Hunan Dongting Pharmaceutical Recent Developments
- 4.8 Major Pharmaceuticals
- 4.8.1 Major Pharmaceuticals Company Information
- 4.8.2 Major Pharmaceuticals Business Overview
- 4.8.3 Major Pharmaceuticals Lorazepam Tablets Sales, Revenue and Gross Margin (2021-2026)
- 4.8.4 Major Pharmaceuticals Lorazepam Tablets Product Portfolio
- 4.8.5 Major Pharmaceuticals Recent Developments
- 4.9 Leading Pharma
- 4.9.1 Leading Pharma Company Information
- 4.9.2 Leading Pharma Business Overview
- 4.9.3 Leading Pharma Lorazepam Tablets Sales, Revenue and Gross Margin (2021-2026)
- 4.9.4 Leading Pharma Lorazepam Tablets Product Portfolio
- 4.9.5 Leading Pharma Recent Developments
- 4.10 Hemofarm
- 4.10.1 Hemofarm Company Information
- 4.10.2 Hemofarm Business Overview
- 4.10.3 Hemofarm Lorazepam Tablets Sales, Revenue and Gross Margin (2021-2026)
- 4.10.4 Hemofarm Lorazepam Tablets Product Portfolio
- 4.10.5 Hemofarm Recent Developments
- 4.11 Bausch Health
- 4.11.1 Bausch Health Company Information
- 4.11.2 Bausch Health Business Overview
- 4.11.3 Bausch Health Lorazepam Tablets Sales, Revenue and Gross Margin (2021-2026)
- 4.11.4 Bausch Health Lorazepam Tablets Product Portfolio
- 4.11.5 Bausch Health Recent Developments
- 4.12 Aurobindo
- 4.12.1 Aurobindo Company Information
- 4.12.2 Aurobindo Business Overview
- 4.12.3 Aurobindo Lorazepam Tablets Sales, Revenue and Gross Margin (2021-2026)
- 4.12.4 Aurobindo Lorazepam Tablets Product Portfolio
- 4.12.5 Aurobindo Recent Developments
5 Global Lorazepam Tablets Market Scenario by Region
- 5.1 Global Lorazepam Tablets Market Size by Region: 2021 VS 2025 VS 2032
- 5.2 Global Lorazepam Tablets Sales by Region: 2021-2032
- 5.2.1 Global Lorazepam Tablets Sales by Region: 2021-2026
- 5.2.2 Global Lorazepam Tablets Sales by Region: 2027-2032
- 5.3 Global Lorazepam Tablets Revenue by Region: 2021-2032
- 5.3.1 Global Lorazepam Tablets Revenue by Region: 2021-2026
- 5.3.2 Global Lorazepam Tablets Revenue by Region: 2027-2032
- 5.4 North America Lorazepam Tablets Market Facts & Figures by Country
- 5.4.1 North America Lorazepam Tablets Market Size by Country: 2021 VS 2025 VS 2032
- 5.4.2 North America Lorazepam Tablets Sales by Country (2021-2032)
- 5.4.3 North America Lorazepam Tablets Revenue by Country (2021-2032)
- 5.4.4 United States
- 5.4.5 Canada
- 5.5 Europe Lorazepam Tablets Market Facts & Figures by Country
- 5.5.1 Europe Lorazepam Tablets Market Size by Country: 2021 VS 2025 VS 2032
- 5.5.2 Europe Lorazepam Tablets Sales by Country (2021-2032)
- 5.5.3 Europe Lorazepam Tablets Revenue by Country (2021-2032)
- 5.5.4 Germany
- 5.5.5 France
- 5.5.6 U.K.
- 5.5.7 Italy
- 5.5.8 Netherlands
- 5.5.9 Nordic Countries
- 5.6 Asia Pacific Lorazepam Tablets Market Facts & Figures by Country
- 5.6.1 Asia Pacific Lorazepam Tablets Market Size by Country: 2021 VS 2025 VS 2032
- 5.6.2 Asia Pacific Lorazepam Tablets Sales by Country (2021-2032)
- 5.6.3 Asia Pacific Lorazepam Tablets Revenue by Country (2021-2032)
- 5.6.4 China
- 5.6.5 Japan
- 5.6.6 South Korea
- 5.6.7 India
- 5.6.8 Australia
- 5.6.9 China Taiwan
- 5.6.10 Southeast Asia
- 5.7 South America Lorazepam Tablets Market Facts & Figures by Country
- 5.7.1 South America Lorazepam Tablets Market Size by Country: 2021 VS 2025 VS 2032
- 5.7.2 South America Lorazepam Tablets Sales by Country (2021-2032)
- 5.7.3 South America Lorazepam Tablets Revenue by Country (2021-2032)
- 5.7.4 Mexico
- 5.7.5 Brazil
- 5.7.6 Argentina
- 5.8 Middle East and Africa Lorazepam Tablets Market Facts & Figures by Country
- 5.8.1 Middle East and Africa Lorazepam Tablets Market Size by Country: 2021 VS 2025 VS 2032
- 5.8.2 Middle East and Africa Lorazepam Tablets Sales by Country (2021-2032)
- 5.8.3 Middle East and Africa Lorazepam Tablets Revenue by Country (2021-2032)
- 5.8.4 Turkey
- 5.8.5 Saudi Arabia
- 5.8.6 UAE
6 Segment by Type
- 6.1 Global Lorazepam Tablets Sales by Type (2021-2032)
- 6.1.1 Global Lorazepam Tablets Sales by Type (2021-2032) & (K Units)
- 6.1.2 Global Lorazepam Tablets Sales Market Share by Type (2021-2032)
- 6.2 Global Lorazepam Tablets Revenue by Type (2021-2032)
- 6.2.1 Global Lorazepam Tablets Sales by Type (2021-2032) & (US$ Million)
- 6.2.2 Global Lorazepam Tablets Revenue Market Share by Type (2021-2032)
- 6.3 Global Lorazepam Tablets Price by Type (2021-2032)
7 Segment by Application
- 7.1 Global Lorazepam Tablets Sales by Application (2021-2032)
- 7.1.1 Global Lorazepam Tablets Sales by Application (2021-2032) & (K Units)
- 7.1.2 Global Lorazepam Tablets Sales Market Share by Application (2021-2032)
- 7.2 Global Lorazepam Tablets Revenue by Application (2021-2032)
- 7.2.1 Global Lorazepam Tablets Sales by Application (2021-2032) & (US$ Million)
- 7.2.2 Global Lorazepam Tablets Revenue Market Share by Application (2021-2032)
- 7.3 Global Lorazepam Tablets Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
- 8.1 Lorazepam Tablets Value Chain Analysis
- 8.1.1 Lorazepam Tablets Key Raw Materials
- 8.1.2 Raw Materials Key Suppliers
- 8.1.3 Lorazepam Tablets Production Mode & Process
- 8.2 Lorazepam Tablets Sales Channels Analysis
- 8.2.1 Direct Comparison with Distribution Share
- 8.2.2 Lorazepam Tablets Distributors
- 8.2.3 Lorazepam Tablets Customers
9 Global Lorazepam Tablets Analyzing Market Dynamics
- 9.1 Lorazepam Tablets Industry Trends
- 9.2 Lorazepam Tablets Industry Drivers
- 9.3 Lorazepam Tablets Industry Opportunities and Challenges
- 9.4 Lorazepam Tablets Industry Restraints
10 Report Conclusion
11 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst